As per NPPA Order S.O. 5690(E) dated 17 October 2026, the trade margin on 137 non-scheduled anti-cancer medicines is capped at 30%. Hetero’s revised MRPs take effect on 9 November 2026.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
KRIS Division specialises in providing comprehensive healthcare solutions across multiple therapeutic areas, including gastrointestinal care, infectious disease management, dermatology, allergy care, antiviral therapies, and pain relief. This division offers a broad portfolio of effective pharmaceutical products formulated to support better health outcomes. Through continuous expansion and therapeutic excellence, KRIS remains dedicated to meeting the evolving needs of healthcare professionals and patients.
View by-